Cargando…

Targeting pathophysiological changes using biomaterials-based drug delivery systems: A key to managing inflammatory bowel disease

Inflammatory bowel disease (IBD) is a gastrointestinal disorder, affecting about several million people worldwide. Current treatments fail to adequately control some clinical symptoms in IBD patients, which can adversely impact the patient’s quality of life. Hence, the development of new treatments...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohajeri, Sahar, Moayedi, Saeed, Mohajeri, Shabnam, Yadegar, Abbas, Haririan, Ismaeil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685402/ https://www.ncbi.nlm.nih.gov/pubmed/36438794 http://dx.doi.org/10.3389/fphar.2022.1045575

Ejemplares similares

Nanobiosensor Based on Sugar Code-AuNPs Aggregation: A Key to Opening New Gates in Rapid Diagnosis of Streptococcal Pharyngitis
por: Mohajeri, Sahar, et al.
Publicado: (2022)

Sugar Codes Conjugated Alginate: An Innovative Platform to Make a Strategic Breakthrough in Simultaneous Prophylaxis of GERD and Helicobacter pylori Infection
por: Moayedi, Saeed, et al.
Publicado: (2020)

The Potential Use of Antibiotics Against Helicobacter pylori Infection: Biopharmaceutical Implications
por: Miri, Amir Hossein, et al.
Publicado: (2022)

Biomaterials for Local, Controlled Drug Delivery to the Injured Spinal Cord
por: Ziemba, Alexis M., et al.
Publicado: (2017)

Medicinal plant-based drug delivery system for inflammatory bowel disease
por: Li, Ningcen, et al.
Publicado: (2023)

Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention
por: Lucafò, Marianna, et al.
Publicado: (2021)

Engineered biomaterial delivery strategies are used to reduce cardiotoxicity in osteosarcoma
por: Hou, Yulin, et al.
Publicado: (2023)

Natural Anti-Inflammatory Compounds as Drug Candidates for Inflammatory Bowel Disease
por: Duan, Linshan, et al.
Publicado: (2021)

Frontiers in Drug Research and Development for Inflammatory Bowel Disease
por: Currò, Diego, et al.
Publicado: (2017)

Advances in Oral Drug Delivery for Regional Targeting in the Gastrointestinal Tract - Influence of Physiological, Pathophysiological and Pharmaceutical Factors
por: Hua, Susan
Publicado: (2020)

Inflammatory pathophysiological mechanisms implicated in postpartum depression
por: Zhu, Jialei, et al.
Publicado: (2022)

Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets
por: Pelaia, Corrado, et al.
Publicado: (2022)

Biomaterials for the Delivery of Growth Factors and Other Therapeutic Agents in Tissue Engineering Approaches to Bone Regeneration
por: Kowalczewski, Christine J., et al.
Publicado: (2018)

Tuning the anticancer activity of a novel pro-apoptotic peptide using gold nanoparticle platforms
por: Akrami, Mohammad, et al.
Publicado: (2016)

Sex Differences in Response to TNF-Inhibiting Drugs in Patients With Spondyloarthropathies or Inflammatory Bowel Diseases
por: Laganà, Bruno, et al.
Publicado: (2019)

Anti Tuberculosis Drug Resistance in West of Iran
por: Mohajeri, Parviz, et al.
Publicado: (2014)

Phylogrouping and characterization of Escherichia coli isolated from colonic biopsies and fecal samples of patients with flare of inflammatory bowel disease in Iran
por: Nadalian, Banafsheh, et al.
Publicado: (2022)

Personalized Medicine of Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacogenetics, Therapeutic Drug Monitoring, and Beyond
por: Di Paolo, Antonello, et al.
Publicado: (2021)

Precision Medicine in Inflammatory Bowel Diseases
por: Marafini, Irene, et al.
Publicado: (2021)

Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery
por: Kalantarian, Pardis, et al.
Publicado: (2010)

Therapeutic Mechanism and Key Alkaloids of Uncaria rhynchophylla in Alzheimer’s Disease From the Perspective of Pathophysiological Processes
por: Zeng, Peng, et al.
Publicado: (2021)

Drug-induced thrombotic microangiopathy: An updated review of causative drugs, pathophysiology, and management
por: Mazzierli, Tommaso, et al.
Publicado: (2023)

Curcumin-loaded nanoliposomes linked to homing peptides for integrin targeting and neuropilin-1-mediated internalization
por: Kangarlou, Sogol, et al.
Publicado: (2016)

Assessment of expenditure control and prescriptive appropriateness of biological drugs in autoimmune diseases and chronic inflammatory bowel disease
por: Capuozzo, Maurizio, et al.
Publicado: (2013)

The Role of Biomaterials as Angiogenic Modulators of Spinal Cord Injury: Mimetics of the Spinal Cord, Cell and Angiogenic Factor Delivery Agents
por: Rocha, Luís A., et al.
Publicado: (2018)

Novel and Emerging Therapies for Inflammatory Bowel Disease
por: Al-Bawardy, Badr, et al.
Publicado: (2021)

Revisiting the Role of Thiopurines in Inflammatory Bowel Disease Through Pharmacogenomics and Use of Novel Methods for Therapeutic Drug Monitoring
por: Lim, Sheng Zhang, et al.
Publicado: (2018)

Using Drosophila melanogaster as a suitable platform for drug discovery from natural products in inflammatory bowel disease
por: Xiu, Minghui, et al.
Publicado: (2022)

Editorial: Relevance of Steroid Biosynthesis, Metabolism and Transport in Pathophysiology and Drug Discovery
por: Rižner, Tea Lanišnik
Publicado: (2019)

Nanoengineered biomaterials for advanced drug delivery
por: Mozafari, Masoud
Publicado: (2020)

Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease
por: Lichnog, Charlotte, et al.
Publicado: (2019)

New Insights Into the Epigenetic Regulation of Inflammatory Bowel Disease
por: Xu, Jing, et al.
Publicado: (2022)

Deciphering the role of autophagy in the immunopathogenesis of inflammatory bowel disease
por: Li, Yue, et al.
Publicado: (2022)

Autophagy in intestinal fibrosis: relevance in inflammatory bowel disease
por: Macias-Ceja, Dulce C., et al.
Publicado: (2023)

Gut Microbiota Metabolism of Azathioprine: A New Hallmark for Personalized Drug-Targeted Therapy of Chronic Inflammatory Bowel Disease
por: Lazarević, Slavica, et al.
Publicado: (2022)

The Suitability of Propolis as a Bioactive Component of Biomaterials
por: Lesmana, Ronny, et al.
Publicado: (2022)

Immunomodulatory biomaterials on chemokine signaling in wound healing
por: Apte, Anisha, et al.
Publicado: (2023)

Immunomodulation and Generation of Tolerogenic Dendritic Cells by Probiotic Bacteria in Patients with Inflammatory Bowel Disease
por: Ghavami, Shaghayegh Baradaran, et al.
Publicado: (2020)

Design and Fabrication of a High Performance Microfluidic Chip for Blood Plasma Separation: Modelling and Prediction of System Behaviour via CFD Method
por: Amini, Hossein, et al.
Publicado: (2023)

Treatment of Recurrent Clostridioides difficile Infection Using Fecal Microbiota Transplantation in Iranian Patients with Underlying Inflammatory Bowel Disease
por: Azimirad, Masoumeh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m24b4eqfnppqu1ljpaevp2f5he